← Back to Patent Explorer
US4668639A Expired / Lapsed US ⏱️ 0.0 years remaining

Biochemical detection method and kit for use therein

Assignee: IQ Bio Ltd
•
Filing: 1984-06-27
•
Granted: 1987-05-26
•
Expires: 2004-06-27
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A biochemical detection method in which a ligand is bound to a surface, an aqueous solution containing an antiligand is brought into contact therewith whereby antiligand becomes bound to ligand, the aqueous solution is separated from the thus bound antiligand, and the antiligand is detected using a detection means associated therewith, for example using amplified enzyme-linked immunoassay. The surface is treated with at least one agent for limiting non-specific binding of either the ligand or the antiligand with other substrates, which agent is (i) a surfactant containing an aromatic residue and having an HLB number of at least 16, (ii) a zwitterionic surfactant, or (iii) a solution containing a salt of a polyvalent anion, in a concentration of at least 100 mM. Preferably, all three agents are used simultaneously. The three agents may be used during the detection procedure in solutions containing the antiligand, in washing solutions used during the method, or in solutions used to pre-treat the plate.

Inventors

  • 👤 Axel Johannsson

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-05 07:33
CPC Classifications
G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/53; G01N33/543; G01N33/54393; Y; Y10; Y10S; Y10S435/00; Y10S435/81; Y10S436/00; Y10S436/825; Y10S436/826

Claims Analysis

Total Claims: 21
Claim 1
Independent Claim 118 words
A biochemical detection method in which a ligand is bound to a surface, an aqueous solution containing an antiligand is brought into contact therewith whereby antiligand becomes bound to ligand, the aqueous solution is separated from the thus bound antiligand, and the antiligand is detected using a detection means associated therewith, wherein the ligand/antiligand combination on the surface is treated with at least one agent for limiting non-specific binding of either the ligand or the antiligand, which agent is (i) a surfactant containing an aromatic residue and having an HLB number of at least 16, (ii) a zwitterionic surfactant, or (iii) a solution containing a salt of a polyvalent anion, in a concentration of at least 100 mM.
Claim 2
Dependent Claim 118 words
A biochemical detection method in which a ligand is bound to a surface, an aqueous solution containing an antiligand is brought into contact therewith whereby antiligand becomes bound to ligand, the aqueous solution is separated from the thus bound antiligand, and the antiligand is detected using a detection means associated therewith, wherein the ligand/antiligand combination on the surface is treated with at least one agent for limiting non-specific binding of either the ligand or the antiligand, which agent is (i) a surfactant containing an aromatic residue and having an HLB number of at least 16, (ii) a zwitterionic surfactant, or (iii) a solution containing a salt of a polyvalent anion, in a concentration of at least 100 mM.
Claim 3
Dependent Claim 65 words
A method as claimed in claim 1, wherein the said agent is a compound of the formula Ar-(OCH 2 CH 2 ) n -OA, wherein Ar is a phenyl group optionally substituted by one or more alkyl groups containing in total from 1 to 14 carbon atoms, n is from 20 to 100, and A is a hydrogen atom, or a methyl or ethyl group.
Claim 4
Dependent Claim 27 words
A method as claimed in claim 2, wherein the group Ar is a phenyl group, substituted by an alkyl group containing from 4 to 12 carbon atoms.
Claim 5
Dependent Claim 11 words
A method as claimed in claim 2, wherein A is hydrogen.
Claim 6
Dependent Claim 17 words
A method as claimed in claim 2, wherein n has a value of from 25 to 80.
Claim 7
Dependent Claim 67 words
A method as claimed in claim 1, wherein the zwitterionic surfactant is a compound of the formula R 1 R 2 NR 3 R 4 wherein R 1 and R 2 are each independently a C 1 -C 6 alkyl group, R 3 is a C 1 -C 6 alkyl group bearing an SO 3 substituent, and R 4 is a C 8 -C 22 alkyl group.
Claim 8
Dependent Claim 18 words
A method as claimed in claim 6, wherein R 1 and R 2 are each a methyl group.
Claim 9
Dependent Claim 28 words
A method as claimed in claim 6 or claim 7, wherein R 3 is a group of the formula CH 2 CH 2 CH 2 SO 3 H
Claim 10
Dependent Claim 41 words
A method as claimed in claim 1, wherein the surface is treated with at least one agent for limiting non-specific binding, which is a solution containing a salt of a polyvalent anion, in a concentration of from 200 to 600 mM.
Claim 11
Dependent Claim 16 words
A method as claimed in claim 9, wherein the polyvalent anion is SO 4 2 .
Claim 12
Dependent Claim 20 words
A method as claimed in claim 9, wherein the polyvalent anion is used in a concentration of about 400 mM.
Claim 13
Dependent Claim 31 words
A method as claimed in claim 1, wherein at least one agent selected from group (iii) is utilized together with at least one agent selected from group (i) or group (ii).
Claim 14
Dependent Claim 24 words
A method as claimed in claim 12, wherein at least one agent from each of the said groups (i), (ii), and (iii) is utilized.
Claim 15
Dependent Claim 54 words
A method as claimed in claim 1, wherein the treatment of the surface with said at least one agent is carried out by including said at least one agent in at least one of the aqueous solutions containing the antiligand, and a solution utilized for washing said surface after treatment with said aqueous solution.
Claim 16
Dependent Claim 134 words
A biological test kit, comprising a first vessel for containing a test liquid, having a surface therein which is covered by the test liquid when in use, and having a first ligand adapted to bind with a corresponding antiligand, bound to said surface, a second vessel containing a reagent solution adapted to bind with antiligand bound with said first ligand, and a third vessel containing a washing solution for washing said first vessel, wherein the reagent solution or the washing solution contains an agent for limiting nonspecific binding of the ligand or antiligand, which is (i) a surfactant containing an aromatic residue and having an HLB number of at least 16, (ii) a zwitterionic surfactant, or (iii) a solution containing a salt of a polyvalent anion, in a concentration of at least 100 mM.
Claim 17
Dependent Claim 134 words
A biological test kit, comprising a first vessel for containing a test liquid, having a surface therein which is covered by the test liquid when in use, and having a first ligand adapted to bind with a corresponding antiligand, bound to said surface, a second vessel containing a reagent solution adapted to bind with antiligand bound with said first ligand, and a third vessel containing a washing solution for washing said first vessel, wherein the reagent solution or the washing solution contains an agent for limiting nonspecific binding of the ligand or antiligand, which is (i) a surfactant containing an aromatic residue and having an HLB number of at least 16, (ii) a zwitterionic surfactant, or (iii) a solution containing a salt of a polyvalent anion, in a concentration of at least 100 mM.
Claim 18
Dependent Claim 89 words
A biochemical detection method in which a ligand is bound to a surface, an aqueous solution containing an antiligand is brought into contact therewith whereby antiligand becomes bound to ligand, the aqueous solution is separated from the thus bound antiligand, and the antiligand is detected using detection means associated therewith, wherein the ligand/antiligand combination on the surface is treated with at least one agent for limiting non-specific binding of either the ligand or the antiligand, which agent is a zwitterionic surfactant having one amine residue and one acidic residue.
Claim 19
Dependent Claim 89 words
A biochemical detection method in which a ligand is bound to a surface, an aqueous solution containing an antiligand is brought into contact therewith whereby antiligand becomes bound to ligand, the aqueous solution is separated from the thus bound antiligand, and the antiligand is detected using detection means associated therewith, wherein the ligand/antiligand combination on the surface is treated with at least one agent for limiting non-specific binding of either the ligand or the antiligand, which agent is a zwitterionic surfactant having one amine residue and one acidic residue.
Claim 20
Dependent Claim 117 words
A biochemical detection method comprising the steps of: contacting an aqueous solution containing an antiligand with a surface having a ligand bound thereto, whereby antiligand binds to ligand to form a complex; treating the ligand/antiligand combination on the surface with at least one agent for limiting non-specific binding of either the ligand or the antiligand said agent being selected from the group consisting of: (i) a surfactant containing an aromatic residue and having an HLB number of at least 16; (ii) a zwitterionic surfactant; and (iii) a solution containing a salt of polyvalent anion, in a concentration of at least 100 mM; separating the aqueous solution from the complex; and detecting the antiligand using a detection means.
Claim 21
Dependent Claim 117 words
A biochemical detection method comprising the steps of: contacting an aqueous solution containing an antiligand with a surface having a ligand bound thereto, whereby antiligand binds to ligand to form a complex; treating the ligand/antiligand combination on the surface with at least one agent for limiting non-specific binding of either the ligand or the antiligand said agent being selected from the group consisting of: (i) a surfactant containing an aromatic residue and having an HLB number of at least 16; (ii) a zwitterionic surfactant; and (iii) a solution containing a salt of polyvalent anion, in a concentration of at least 100 mM; separating the aqueous solution from the complex; and detecting the antiligand using a detection means.

References Cited (Backward Citations)

US4060597A Cited
US4256724A Cited
US4319882A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1990-05-25 1990-11-24 1991-05-26 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1994-05-25 1994-11-24 1995-05-26 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1998-05-25 1998-11-24 1999-05-26 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag